Search results
CAR T cells in lupus: Promising results at EULAR 2024 and emergence of China
Clinical Trials Arena· 2 days agoKYV-101 Kyverna Therapeutics Inc Phase I/II US, Germany YTB323 (rapcabtagene autoleucel) Novartis AG...
KYV-101 Kyverna Therapeutics Inc Phase I/II US, Germany YTB323 (rapcabtagene autoleucel) Novartis AG...